$600 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 121 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 22.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | R1 RCM INC | $14,929,629 | +4.9% | 809,194 | -14.7% | 2.49% | -9.0% | |
| EVH | Sell | EVOLENT HEALTH INCcl a | $14,790,703 | -7.2% | 488,142 | -0.6% | 2.47% | -19.5% |
| PRVA | Buy | PRIVIA HEALTH GROUP | $13,227,900 | +70.9% | 506,622 | +80.7% | 2.20% | +48.3% |
| APLS | Sell | APELLIS PHARMACEUTIC | $13,105,555 | +15.2% | 143,859 | -16.6% | 2.18% | -0.1% |
| RDNT | Buy | RADNET INC | $13,003,441 | +66.0% | 398,634 | +27.4% | 2.17% | +44.1% |
| BMRN | Buy | BIOMARIN PHARMAC INC | $12,867,473 | +6.3% | 148,448 | +19.3% | 2.14% | -7.7% |
| OPCH | Buy | OPTION CARE HEALTH | $12,671,100 | +33.6% | 390,000 | +30.7% | 2.11% | +15.9% |
| ICLR | Sell | ICON PLC | $12,002,594 | +11.2% | 47,972 | -5.1% | 2.00% | -3.6% |
| ATRC | Buy | ATRICURE INC | $11,823,300 | +78.8% | 239,532 | +50.1% | 1.97% | +55.1% |
| HQY | HEALTHEQUITY INC | $11,578,298 | +7.5% | 183,375 | 0.0% | 1.93% | -6.7% | |
| LLY | LILLY ELI & CO | $11,145,310 | +36.6% | 23,765 | 0.0% | 1.86% | +18.4% | |
| UNH | Sell | UNITEDHEALTH GRP INC | $11,018,672 | -10.6% | 22,925 | -12.1% | 1.84% | -22.4% |
| INSM | Buy | INSMED INC | $10,926,445 | +24.2% | 517,841 | +0.3% | 1.82% | +7.7% |
| Buy | MINERALYS THERAPEUTI | $10,480,857 | +9.1% | 614,713 | +0.2% | 1.75% | -5.4% | |
| PRTA | Buy | PROTHENA CORP PLC | $10,368,181 | +74.3% | 151,848 | +23.7% | 1.73% | +51.1% |
| JNJ | JOHNSON & JOHNSON | $10,278,792 | +6.8% | 62,100 | 0.0% | 1.71% | -7.4% | |
| TMCI | Buy | TREACE MED CONCEPT | $9,706,152 | +5.2% | 379,443 | +3.5% | 1.62% | -8.8% |
| PTCT | Buy | PTC THERAPEUTICS I | $9,423,076 | -14.1% | 231,696 | +2.3% | 1.57% | -25.5% |
| New | MOONLAKE IMMUNOTHERAcl a | $9,414,090 | – | 184,590 | +100.0% | 1.57% | – | |
| FOLD | Buy | AMICUS THERAPEUTICS | $9,167,845 | +59.0% | 729,924 | +40.4% | 1.53% | +38.0% |
| NARI | INARI MED INC | $8,897,920 | -5.8% | 153,043 | 0.0% | 1.48% | -18.3% | |
| BPMC | Buy | BLUEPRINT MEDICINES | $8,648,098 | +57.7% | 136,837 | +12.3% | 1.44% | +36.8% |
| SBTX | Buy | ARS PHARMACEUTICALS | $8,412,788 | +62.8% | 1,255,640 | +58.2% | 1.40% | +41.3% |
| Buy | AMYLYX PHARMACEUTIC | $8,354,277 | +17.5% | 387,310 | +59.8% | 1.39% | +1.9% | |
| LNTH | Sell | LANTHEUS HLDGS INC | $8,281,813 | -14.8% | 98,687 | -16.1% | 1.38% | -26.0% |
| IMGN | Sell | IMMUNOGEN INC | $8,235,755 | +114.2% | 436,447 | -56.4% | 1.37% | +85.8% |
| INSP | Sell | INSPIRE MED SYS INC | $7,791,360 | +21.0% | 24,000 | -12.7% | 1.30% | +5.0% |
| AGLY | Sell | AGILITI INC | $7,743,071 | -5.0% | 469,277 | -8.0% | 1.29% | -17.6% |
| ITCI | Buy | INTRA CELLULAR THERA | $7,589,029 | +22.7% | 119,852 | +4.9% | 1.26% | +6.4% |
| ALKS | Buy | ALKERMES PLC | $7,580,015 | +16.4% | 242,173 | +4.8% | 1.26% | +1.0% |
| THC | Sell | TENET HEALTHCARE | $7,446,270 | +23.5% | 91,500 | -9.9% | 1.24% | +7.2% |
| DNLI | Buy | DENALI THERAPEUTICS | $7,238,537 | +28.3% | 245,291 | +0.2% | 1.21% | +11.3% |
| RCUS | Buy | ARCUS BIOSCIENCES | $7,199,692 | +34.4% | 354,490 | +20.7% | 1.20% | +16.6% |
| TVTX | Buy | TRAVERE THERAPEUTICS | $6,686,408 | -17.1% | 435,313 | +21.4% | 1.12% | -28.1% |
| ZNTL | ZENTALIS PHARMACEU | $6,601,140 | +64.0% | 234,000 | 0.0% | 1.10% | +42.2% | |
| AXNX | Buy | AXONICS INC | $6,457,637 | +7.6% | 127,950 | +16.4% | 1.08% | -6.6% |
| MMSI | New | MERIT MEDICAL SYS | $6,356,640 | – | 76,000 | +100.0% | 1.06% | – |
| MRK | MERCK & CO INC | $6,346,450 | +8.5% | 55,000 | 0.0% | 1.06% | -6.0% | |
| AMGN | Buy | AMGEN INC | $6,276,283 | +18.4% | 28,269 | +29.0% | 1.05% | +2.8% |
| GRTX | Sell | GALERA THERAPEUTIC | $6,255,769 | +16.4% | 2,005,054 | -4.5% | 1.04% | +1.0% |
| CNMD | New | CONMED CORP | $6,182,995 | – | 45,500 | +100.0% | 1.03% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS | $6,006,460 | +76.4% | 52,449 | +112.3% | 1.00% | +52.8% |
| OLMA | Sell | OLEMA PHARMACEUTICAL | $5,854,628 | +69.4% | 648,353 | -34.9% | 0.98% | +47.0% |
| PFE | PFIZER INC | $5,773,432 | -10.1% | 157,400 | 0.0% | 0.96% | -22.0% | |
| ALNY | Buy | ALNYLAM PHARMACUETCL | $5,665,150 | +6.4% | 29,826 | +12.3% | 0.94% | -7.6% |
| VERA | Sell | VERA THERAPEUTICScl a | $5,643,918 | +21.2% | 351,646 | -41.4% | 0.94% | +5.1% |
| KRTX | Sell | KARUNA THERAPEUTICS | $5,579,984 | +14.3% | 25,732 | -4.3% | 0.93% | -0.9% |
| REPL | Sell | REPLIMUNE GROUP INC | $5,538,922 | +19.6% | 238,541 | -9.0% | 0.92% | +3.7% |
| ABT | Buy | ABBOTT LABS | $5,478,037 | +53.5% | 50,248 | +42.6% | 0.91% | +33.1% |
| PCVX | Buy | VAXCYTE INC | $5,442,311 | +142.0% | 108,977 | +81.6% | 0.91% | +110.0% |
| SWAV | Sell | SHOCKWAVE MEDICAL | $5,408,520 | -60.1% | 18,950 | -69.7% | 0.90% | -65.4% |
| MRTX | Buy | MIRATI THERAPEUTICS | $5,367,220 | +12.4% | 148,553 | +15.7% | 0.90% | -2.5% |
| BSX | Sell | BOSTON SCIENTIFIC | $5,353,612 | +4.9% | 98,976 | -2.9% | 0.89% | -9.0% |
| ABBV | ABBVIE INC | $5,294,889 | -15.5% | 39,300 | 0.0% | 0.88% | -26.7% | |
| ARWR | New | ARROWHEAD PHARMACEUT | $5,132,259 | – | 143,922 | +100.0% | 0.86% | – |
| HALO | Buy | HALOZYME THERAPEUTIC | $5,029,493 | +12.2% | 139,437 | +18.8% | 0.84% | -2.7% |
| IQV | Buy | IQVIA HOLDINGS INC | $4,967,417 | +53.2% | 22,100 | +35.6% | 0.83% | +32.9% |
| GKOS | New | GLAUKOS CORP | $4,913,490 | – | 69,000 | +100.0% | 0.82% | – |
| RETA | Buy | REATA PHARMACEUTICcl a | $4,843,100 | +113.1% | 47,500 | +90.0% | 0.81% | +84.7% |
| Sell | 2SEVENTY BIO INC | $4,680,348 | -3.6% | 462,485 | -2.8% | 0.78% | -16.4% | |
| MDGL | Buy | MADRIGAL PHARMACEUTI | $4,385,535 | +3520.5% | 18,985 | +3697.0% | 0.73% | +3078.3% |
| New | ACELYRIN INC | $4,201,255 | – | 201,017 | +100.0% | 0.70% | – | |
| OCUL | New | OCULAR THERAPEUTIX | $4,141,829 | – | 802,680 | +100.0% | 0.69% | – |
| NTLA | Buy | INTELLIA THERAPEUT | $4,111,929 | +4348.7% | 100,832 | +3965.8% | 0.69% | +3711.1% |
| BIIB | Buy | BIOGEN INC | $4,006,700 | +10.8% | 14,066 | +8.2% | 0.67% | -3.9% |
| CYTK | Buy | CYTOKINETICS INC | $3,819,248 | +29.4% | 117,083 | +39.6% | 0.64% | +12.3% |
| RCKT | ROCKET PHARMACEUTICA | $3,790,997 | +16.0% | 190,790 | 0.0% | 0.63% | +0.6% | |
| TMO | Sell | THERMO FISHER SCI | $3,738,339 | -18.6% | 7,165 | -10.0% | 0.62% | -29.4% |
| PODD | New | INSULET CORP | $3,604,250 | – | 12,500 | +100.0% | 0.60% | – |
| MDT | MEDTRONIC PLC | $3,528,493 | +9.3% | 40,051 | 0.0% | 0.59% | -5.3% | |
| EW | Buy | EDWARDS LIFESCIENCE | $3,367,581 | +27.6% | 35,700 | +11.9% | 0.56% | +10.7% |
| BMY | BRISTOL MYERS SQUIBB | $3,197,500 | -7.7% | 50,000 | 0.0% | 0.53% | -20.0% | |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $3,129,600 | -57.3% | 30,000 | -49.3% | 0.52% | -63.0% |
| VRTX | Buy | VERTEX PHARMACEUTICL | $2,872,993 | +37.8% | 8,164 | +23.3% | 0.48% | +19.5% |
| EYPT | New | EYEPOINT PHARMA | $2,708,110 | – | 311,277 | +100.0% | 0.45% | – |
| DHR | Sell | DANAHER CORP | $2,634,000 | -10.1% | 10,975 | -5.6% | 0.44% | -22.0% |
| SILK | Sell | SILK ROAD MEDICAL | $2,615,445 | -30.1% | 80,500 | -15.8% | 0.44% | -39.4% |
| GILD | Buy | GILEAD SCIENCES INC | $2,518,802 | +18.1% | 32,682 | +27.2% | 0.42% | +2.4% |
| ANNX | Buy | ANNEXON INC | $2,374,694 | +88.7% | 674,629 | +106.4% | 0.40% | +63.6% |
| REGN | Buy | REGENERON PHARMCTCLS | $2,296,454 | +0.2% | 3,196 | +14.6% | 0.38% | -13.2% |
| Sell | RALLYBIO CORP | $2,127,934 | -32.5% | 375,960 | -31.9% | 0.36% | -41.4% | |
| New | EQRX INC | $2,112,899 | – | 1,135,967 | +100.0% | 0.35% | – | |
| PMVP | Buy | PMV PHARMACEUTICALS | $2,079,885 | +74.1% | 332,250 | +32.7% | 0.35% | +50.9% |
| BEAM | BEAM THERAPEUTICS | $2,027,555 | +4.3% | 63,500 | 0.0% | 0.34% | -9.6% | |
| EFFECTOR THERAPEUTCS | $1,978,071 | +135.4% | 2,382,644 | 0.0% | 0.33% | +103.7% | ||
| GBIO | Sell | GENERATION BIO CO | $1,962,070 | +18.5% | 356,740 | -7.4% | 0.33% | +2.8% |
| ITOS | Buy | ITEOS THERAPEUTICS | $1,940,666 | +61.4% | 146,576 | +65.9% | 0.32% | +40.3% |
| ALLK | New | ALLAKOS INC | $1,893,592 | – | 434,310 | +100.0% | 0.32% | – |
| MGNX | New | MACROGENICS INC | $1,885,859 | – | 352,497 | +100.0% | 0.31% | – |
| AVIR | Buy | ATEA PHARMACEUTICALS | $1,875,748 | +47.0% | 501,537 | +31.7% | 0.31% | +27.8% |
| STRO | New | SUTRO BIOPHARMA IN | $1,863,004 | – | 400,646 | +100.0% | 0.31% | – |
| SRRK | Buy | SCHOLAR ROCK HLDG | $1,852,842 | +72.1% | 245,735 | +82.6% | 0.31% | +49.3% |
| TELA | New | TELA BIO INC | $1,806,908 | – | 178,372 | +100.0% | 0.30% | – |
| BCAB | Buy | BIOATLA INC | $1,669,554 | +14.7% | 556,518 | +2.5% | 0.28% | -0.7% |
| HUM | HUMANA INC | $1,598,490 | -7.9% | 3,575 | 0.0% | 0.27% | -20.1% | |
| MRNA | Sell | MODERNA INC | $1,558,602 | -42.7% | 12,828 | -27.6% | 0.26% | -50.3% |
| SGEN | Sell | SEAGEN INC | $1,542,567 | -60.6% | 8,015 | -58.6% | 0.26% | -65.9% |
| AZN | Buy | ASTRAZENECAspn adr | $1,519,145 | +9.4% | 21,226 | +6.1% | 0.25% | -5.2% |
| XBI | Sell | SPDR SER TRs&p biotech | $1,500,262 | -54.6% | 18,032 | -58.4% | 0.25% | -60.6% |
| BGNE | Buy | BEIGENE LIMITEDspn adr | $1,034,140 | -12.9% | 5,800 | +5.3% | 0.17% | -24.6% |
| ILMN | Buy | ILLUMINA INC | $1,018,446 | -3.1% | 5,432 | +20.2% | 0.17% | -15.8% |
| HZNP | Buy | HORIZON THERAPEUTICS | $812,412 | +26.2% | 7,899 | +33.9% | 0.14% | +8.9% |
| SNY | Buy | SANOFIspn adr | $587,294 | +21.3% | 10,896 | +22.4% | 0.10% | +5.4% |
| LEGN | Sell | LEGEND BIOTECH CORPspn adr | $552,240 | +14.5% | 8,000 | -20.0% | 0.09% | -1.1% |
| INCY | Buy | INCYTE CORPORATION | $509,081 | +5.5% | 8,178 | +22.4% | 0.08% | -8.6% |
| RDY | DR REDDYS LABS LTDadr | $505,132 | +10.9% | 8,004 | 0.0% | 0.08% | -4.5% | |
| UTHR | Buy | UNITED THERAPEUTICS | $496,025 | +22.0% | 2,247 | +23.8% | 0.08% | +6.4% |
| RPRX | Buy | ROYALTY PHARMA PLC | $472,228 | +5.4% | 15,362 | +23.5% | 0.08% | -8.1% |
| JAZZ | Buy | JAZZ PHARMA PLC | $413,316 | +30.2% | 3,334 | +53.6% | 0.07% | +13.1% |
| ARGX | Buy | ARGENX SEspn adr | $410,775 | +29.7% | 1,054 | +24.0% | 0.07% | +11.5% |
| BNTX | Buy | BIONTECH SEspn adr | $359,299 | +6.8% | 3,329 | +23.3% | 0.06% | -7.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENC | $326,278 | +15.1% | 3,460 | +23.6% | 0.05% | 0.0% |
| TPST | New | TEMPEST THERAPEUTICS | $278,630 | – | 219,394 | +100.0% | 0.05% | – |
| MEDP | Buy | MEDPACE HOLDINGS | $270,431 | +48.3% | 1,126 | +16.1% | 0.04% | +28.6% |
| FUSN | FUSION PHARMACEUTI | $267,577 | +23.9% | 57,297 | 0.0% | 0.04% | +7.1% | |
| Buy | ROIVANT SCIENCES LTD | $256,304 | +65.4% | 25,427 | +21.1% | 0.04% | +43.3% | |
| ASND | Buy | ASCENDIS PHARMA A Sspn adr | $249,543 | +37.7% | 2,796 | +65.4% | 0.04% | +20.0% |
| ZLAB | Sell | ZAI LAB LTDadr | $221,840 | -44.1% | 8,000 | -32.9% | 0.04% | -51.3% |
| ARVN | Sell | ARVINAS INC | $153,264 | -97.3% | 6,175 | -97.0% | 0.03% | -97.6% |
| ARQT | Sell | ARCUTIS BIOTHERAPE | $136,155 | -96.1% | 14,287 | -95.5% | 0.02% | -96.6% |
| SMMT | Buy | SUMMIT THERAPEUTICS | $125,500 | +258.6% | 50,000 | +150.0% | 0.02% | +200.0% |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -1,750 | -100.0% | -0.02% | – |
| Exit | EXSCIENTIA PLCads | $0 | – | -210,303 | -100.0% | -0.21% | – | |
| PNT | Exit | POINT BIOPHARMA GBL | $0 | – | -182,668 | -100.0% | -0.26% | – |
| FDMT | Exit | 4D MOLECULAR THERA | $0 | – | -80,029 | -100.0% | -0.26% | – |
| MRSN | Exit | MERSANA THERAPEUTI | $0 | – | -343,079 | -100.0% | -0.27% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -479,100 | -100.0% | -0.39% | – |
| ALHC | Exit | ALIGNMENT HEALTHCA | $0 | – | -471,000 | -100.0% | -0.58% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -184,000 | -100.0% | -0.65% | – |
| RAIN | Exit | RAIN ONCOLOGY INC | $0 | – | -484,928 | -100.0% | -0.82% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -1,253,300 | -100.0% | -1.01% | – |
| BLU | Exit | BELLUS HEALTH INC | $0 | – | -767,829 | -100.0% | -1.06% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENC | $0 | – | -108,090 | -100.0% | -2.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 41 | Q2 2023 | 6.7% |
| PTC THERAPEUTICS INC | 41 | Q2 2023 | 2.7% |
| DR REDDYS LABS LTD | 41 | Q2 2023 | 2.0% |
| GILEAD SCIENCES INC | 37 | Q2 2023 | 8.4% |
| INCYTE CORPORATION | 37 | Q2 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 37 | Q2 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 36 | Q2 2023 | 6.6% |
| PFIZER INC | 34 | Q2 2023 | 6.3% |
| MERCK & CO. INC | 33 | Q2 2023 | 6.4% |
| MEDTRONIC PLC | 32 | Q2 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | February 13, 2023 | 2,382,644 | 5.7% |
| Galera Therapeutics, Inc. | February 13, 2023 | 1,666,666 | 5.8% |
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.